Signaling Pathways - adrenoceptor - Insulin-like growth factors (IGFs) - Angiotensin AT1 Receptors - Reverse Transcriptases
清除全部
- B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1拮抗剂
- B2224 Etravirine (TMC125)中文名: 依曲韦林Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- B2214 Valsartan中文名: 缬沙坦Target: Angiotensin AT1 ReceptorsSummary: 血管紧张素II AT1受体拮抗剂
- B2223 Zalcitabine中文名: 扎西他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂
- B1007 AVE 09911 CitationTarget: Angiotensin AT1 ReceptorsSummary: 血管紧张素-(1-7)受体激动剂
- B2210 Azilsartan中文名: 阿齐沙坦Target: Angiotensin AT1 ReceptorsSummary: 强效血管紧张素II 1型(AT1)受体反向激动剂
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂
- A8554 Dapivirine (TMC120)中文名: 达匹维林Target: Reverse TranscriptasesSummary: 非核苷逆转录酶抑制剂
- A8474 Mirabegron (YM178)中文名: 米拉贝隆Target: adrenoceptorSummary: 选择性β3肾上腺素受体激动剂
- A8422 Emtricitabine1 Citation中文名: 恩曲他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂